Ron D. Henriksen
Gründer bei Twilight Venture Partners LLC
Profil
Ron D.
Henriksen was the founder of EndGenitor Technologies, Inc. (founded in 2005) where he served as the Chairman, President & Chief Executive Officer from 2012 to 2013.
He is also the founder of Twilight Venture Partners LLC.
Currently, Mr. Henriksen is a Partner & Chief Investment Officer at Twilight Venture Partners LLC since 2002.
Mr. Henriksen's former positions include being the President & Chief Executive Officer of Khepri Pharmaceuticals, Inc. from 1993 to 1995, Chief Executive Officer of Itasca Ventures LLC from 1996 to 1998, Chairman of Semafore Pharmaceuticals, Inc., Chairman of Plus Therapeutics, Inc. from 2002 to 2011, Managing Director-Brazil, Mexico & Central America at Eli Lilly & Co. from 1971 to 1994, Director at QLT, Inc. from 1997 to 2007, and President of IU Ventures in 2002.
In terms of education, Mr. Henriksen holds an MBA from Harvard University (conferred in 1967), an undergraduate degree from Iowa State University (conferred in 1961), and another MBA from Harvard Business School.
Aktive Positionen von Ron D. Henriksen
| Unternehmen | Position | Beginn |
|---|---|---|
Twilight Venture Partners LLC
 Twilight Venture Partners LLC Investment ManagersFinance Twilight Venture Partners LLC (Twilight Venture Partners) is a venture capital firm founded in 2002 by Jim R. Baumgardt, Harry L. Gonso, and Ronald D. Henriksen. The firm is headquartered in Indianapolis, Indiana. | Gründer | 01.01.2002 |
Ehemalige bekannte Positionen von Ron D. Henriksen
| Unternehmen | Position | Ende |
|---|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | 01.01.2007 |
| MacroPore Biosurgery, Inc. /Old/ | Direktor/Vorstandsmitglied | 15.07.2005 |
IU Ventures
 IU Ventures Investment ManagersFinance IU Ventures (IU ventures) is a venture capital subsidiary of Indiana University founded in 1997. The firm is headquartered in Bloomington, Indiana. | Präsident | 01.01.2002 |
| Itasca Ventures LLC | Präsident | 01.01.1998 |
Khepri Pharmaceuticals, Inc.
 Khepri Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Quest Diagnostics, Inc., Khepri Pharmaceuticals, Inc. is a developer of pharmaceutical products. The company is based in South San Francisco, CA. The company was founded by Donald G. Payan. Khepri Pharmaceuticals was acquired by Arris Pharmaceutical Corp. on December 26, 1995 for $33.40 million. | Präsident | 01.01.1995 |
Ausbildung von Ron D. Henriksen
| Iowa State University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| PLUS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 13 |
|---|---|
| MacroPore Biosurgery, Inc. /Old/ | Health Technology |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Khepri Pharmaceuticals, Inc.
Khepri Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Quest Diagnostics, Inc., Khepri Pharmaceuticals, Inc. is a developer of pharmaceutical products. The company is based in South San Francisco, CA. The company was founded by Donald G. Payan. Khepri Pharmaceuticals was acquired by Arris Pharmaceutical Corp. on December 26, 1995 for $33.40 million. | Commercial Services |
BioStorage Technologies, Inc.
 BioStorage Technologies, Inc. Drugstore ChainsRetail Trade BioStorage Technologies, Inc. provides biological sample storage, DNA storage, shipping, tracking and reporting services. The firm provides sample management consulting, supply chain, logistics, relocation, preparation, storage, and business continuity consulting and disaster recovery services. It offers onsite, offsite and hybrid sample outsourcing models for the management of sample assets. The company was founded by F. John Mills and Oscar Moralez in 2002 and is headquartered in Indianapolis, IN. | Retail Trade |
EndGenitor Technologies, Inc.
 EndGenitor Technologies, Inc. BiotechnologyHealth Technology EndGenitor Technologies, Inc. commercialized adult stem cell products. It was an adult stem cell company, and the outcome of its studies may support the filing of regulatory applications for clinical trials for human disease and tissue dysfunction. The company was founded by Ronald D. Henriksen, Carlos Lopez, Merv Yonder and Dave Ingram in 2005 and was headquartered in Indianapolis, IN. | Health Technology |
ANGEL Learning, Inc.
 ANGEL Learning, Inc. Packaged SoftwareTechnology Services ANGEL Learning, Inc. develops and markets enterprise learning software. It offers ANGEL Learning Management Suite and the ANGEL ePortfolio system. The company was founded in 2000 and is headquartered in Indianapolis, IN. | Technology Services |
PreMD, Inc.
 PreMD, Inc. Medical SpecialtiesHealth Technology PreMD, Inc. engages in manufacturing and distribution of pharmaceutical products. The company was founded by H. B. Brent Norton on November 9, 1992 and is headquartered in Toronto, Canada. | Health Technology |
| Itasca Ventures LLC | |
StemSource, Inc.
 StemSource, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Plus Therapeutics, Inc., StemSource, Inc. develops treatments for cancer. The company is based in Thousand Oaks, CA. The company was founded by Adam J. Katz, Marc H. Hedrick. StemSource was acquired by MacroPore Biosurgery, Inc. on November 30, 2002 for $5.71 million. | Commercial Services |
IU Ventures
IU Ventures Investment ManagersFinance IU Ventures (IU ventures) is a venture capital subsidiary of Indiana University founded in 1997. The firm is headquartered in Bloomington, Indiana. | Finance |
| United States Navy (District of Columbia) | Government |
Semafore Pharmaceuticals, Inc.
 Semafore Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Semafore Pharmaceuticals, Inc. develops and discovers drugs for multiple disorders including cancer. The company was founded by Christopher J. Garlich and Ronald Michal in 2000 and is headquartered in Indianapolis, IN. | Retail Trade |
Twilight Venture Partners LLC
Twilight Venture Partners LLC Investment ManagersFinance Twilight Venture Partners LLC (Twilight Venture Partners) is a venture capital firm founded in 2002 by Jim R. Baumgardt, Harry L. Gonso, and Ronald D. Henriksen. The firm is headquartered in Indianapolis, Indiana. | Finance |
